Related Experiment Video

Updated: Jul 16, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study

Christiane Reitz1, Frank J A van Rooij, Moniek P M de Maat

  • 1Department of Epidemiology and Biostatistics, Erasmus Medical Center, P.O. Box 1738, 3000DR Rotterdam, The Netherlands.

Neurobiology of Aging
|February 24, 2007
PubMed

Insights

Genetic variations in the MMP3 gene do not appear to influence Alzheimer's disease (AD) risk or cognitive decline in the elderly. This study found no link between MMP3-haplotypes and dementia, cognitive performance, or brain changes associated with AD.

Area of Science:

  • Neuroscience
  • Genetics
  • Gerontology

Background:

  • Matrix metalloproteinases (MMPs), particularly MMP3, are implicated in Alzheimer's disease (AD) pathophysiology, potentially through amyloid beta degradation.
  • Previous research suggests a possible role for MMPs in AD development, warranting further investigation into specific gene variants.

Purpose of the Study:

  • To investigate the association between MMP3-haplotypes and cognitive performance over time in elderly individuals.
  • To determine if MMP3-haplotypes are linked to the risk of dementia and AD.
  • To explore the relationship between MMP3-haplotypes and neuroimaging markers, including hippocampal volume and white matter lesions (WML).

Main Methods:

  • A large cohort of 5999 elderly individuals was studied.
  • MMP3-haplotypes and individual polymorphisms were analyzed for associations with cognitive decline (MMSE), dementia, and AD diagnosis.
  • Neuroimaging data (hippocampal volume, WML severity) were assessed in relation to MMP3 genotypes and haplotypes.
  • Analyses were stratified by APOEepsilon4 genotype status.

Main Results:

  • No significant association was found between any MMP3 polymorphism or haplotype and cognitive performance (MMSE) over time.
  • MMP3 genotypes or haplotypes were not associated with an increased risk of dementia or AD.
  • No correlation was observed between MMP3 variations and changes in hippocampal volume or the severity of white matter lesions.
  • These findings remained consistent regardless of APOEepsilon4 carrier status.

Conclusions:

  • Variation within the MMP3 gene does not appear to be a significant causal factor in the development of dementia or Alzheimer's disease.
  • The investigated MMP3 genetic variations do not influence cognitive trajectories or key neuropathological markers in the elderly population.
  • Further research may be needed to explore other genetic or environmental factors contributing to AD pathogenesis.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...